PanTera
Mol
About PanTera
PanTera focuses on the large-scale production of actinium-225, a promising radioisotope for targeted cancer therapies. The company aims to improve accessibility to personalized nuclear medicine treatments while ensuring sustainability through the recycling of materials in their production process.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $147.5M
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2024)
- Website: pantera-life.com
- Phone: [email protected]
Industries & Categories
Health Care, Manufacturing, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/pantera-51609 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.